Share
Mike D’Ambrosio
Parexel, a leading clinical research organization, has enhanced its Real World Research (RWR) offering by integrating its Scientific Data Organization (SDO) and Real World Evidence (RWE) capabilities to better address evolving customer needs.
As part of this strategic initiative, Parexel has appointed Mike D’Ambrosio as Senior Vice President, Global Head of Real World Research. In this role, D’Ambrosio will lead efforts to expand customer engagement and optimize the delivery of Real World Data (RWD) and RWE services, helping to ensure the safety and efficacy of new therapies through a deeper understanding of patient experiences and outcomes.
D’Ambrosio, who previously served as Vice President, Head of Real World Evidence Solutions at Syneos Health, brings significant experience in developing RWE strategies, operations, and thought leadership. His expertise will play a key role in strengthening Parexel’s position as a trusted partner for evidence generation throughout the drug development process.
